View in EDS HTML Full Text PDF Full Text

A disulfide-bridged single-stranded DNA nanotube for co-delivery of siRNA and chemotherapeutics in ovarian cancer therapy.

Saved in:
Bibliographic Details
Title: A disulfide-bridged single-stranded DNA nanotube for co-delivery of siRNA and chemotherapeutics in ovarian cancer therapy.
Authors: Luo Y; Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China., Guo A; Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China., Sheng T; Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China., Han L; Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China., Gu C; Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China., Li X; Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China., Chen C; College of Information Science and Technology, Beijing University of Chemical Technology, Beijing, China., Shi X; School of Computer Science and Cyber Engineering, Guangzhou University, Guangzhou, China.
Source: Frontiers in medicine [Front Med (Lausanne)] 2026 May 28; Vol. 13, pp. 1798117. Date of Electronic Publication: 2026 May 28 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42292175
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A disulfide-bridged single-stranded DNA nanotube for co-delivery of siRNA and chemotherapeutics in ovarian cancer therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Luo+Y%22">Luo Y</searchLink>; Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Guo+A%22">Guo A</searchLink>; Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Sheng+T%22">Sheng T</searchLink>; Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Han+L%22">Han L</searchLink>; Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Gu+C%22">Gu C</searchLink>; Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Chen+C%22">Chen C</searchLink>; College of Information Science and Technology, Beijing University of Chemical Technology, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Shi+X%22">Shi X</searchLink>; School of Computer Science and Cyber Engineering, Guangzhou University, Guangzhou, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101648047%22">Frontiers in medicine</searchLink> [Front Med (Lausanne)] 2026 May 28; Vol. 13, pp. 1798117. <i>Date of Electronic Publication: </i>2026 May 28 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+S%2EA%22">Frontiers Media S.A </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101648047 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2296-858X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222296858X%22">2296858X </searchLink><i>NLM ISO Abbreviation: </i>Front Med (Lausanne) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42292175
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fmed.2026.1798117
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1798117
    Titles:
      – TitleFull: A disulfide-bridged single-stranded DNA nanotube for co-delivery of siRNA and chemotherapeutics in ovarian cancer therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Luo Y
      – PersonEntity:
          Name:
            NameFull: Guo A
      – PersonEntity:
          Name:
            NameFull: Sheng T
      – PersonEntity:
          Name:
            NameFull: Han L
      – PersonEntity:
          Name:
            NameFull: Gu C
      – PersonEntity:
          Name:
            NameFull: Li X
      – PersonEntity:
          Name:
            NameFull: Chen C
      – PersonEntity:
          Name:
            NameFull: Shi X
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 05
              Text: 2026 May 28
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2296-858X
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: Frontiers in medicine
              Type: main
ResultId 1